smallAccCompHo_0921.xslt
01/04/2025 30/04/2026 false false false Easy Digital Filing 2020_1 16357563 business:PrivateLimitedCompanyLtd 2025-04-01 2026-04-30 16357563 2025-04-01 16357563 2026-04-30 16357563 2025-04-01 2026-04-30 16357563 2025-04-01 16357563 2025-04-01 16357563 2025-04-01 2025-04-01 16357563 business:Director1 2025-04-01 2026-04-30 16357563 business:Director2 2025-04-01 2026-04-30 16357563 business:AuditExempt-NoAccountantsReport 2025-04-01 2026-04-30 16357563 business:FRS102 2025-04-01 2026-04-30 16357563 business:AbridgedAccounts 2025-04-01 2026-04-30 16357563 core:WithinOneYear 2026-04-30 16357563 core:WithinOneYear 2025-03-31 16357563 core:AfterOneYear 2026-04-30 16357563 core:AfterOneYear 2025-03-31 16357563 core:Goodwill 2025-04-01 2026-04-30 16357563 core:Goodwill 2025-04-01 16357563 core:Goodwill 2026-04-30 16357563 core:IntangibleAssetsOtherThanGoodwill 2025-04-01 2026-04-30 16357563 core:IntangibleAssetsOtherThanGoodwill 2025-04-01 16357563 core:IntangibleAssetsOtherThanGoodwill 2026-04-30 16357563 core:LandBuildings 2025-04-01 2026-04-30 16357563 core:LandBuildings 2025-04-01 16357563 core:LandBuildings 2026-04-30 16357563 core:PlantMachinery 2025-04-01 2026-04-30 16357563 core:PlantMachinery 2025-04-01 16357563 core:PlantMachinery 2026-04-30 16357563 core:MotorVehicles 2025-04-01 2026-04-30 16357563 core:MotorVehicles 2025-04-01 16357563 core:MotorVehicles 2026-04-30 16357563 core:FurnitureFittingsToolsEquipment 2025-04-01 2026-04-30 16357563 core:FurnitureFittingsToolsEquipment 2025-04-01 16357563 core:FurnitureFittingsToolsEquipment 2026-04-30 16357563 core:ComputerEquipment 2025-04-01 2026-04-30 16357563 core:ComputerEquipment 2025-04-01 16357563 core:ComputerEquipment 2026-04-30 16357563 core:ShareCapital 2025-03-31 16357563 core:ShareCapital 2026-04-30 16357563 core:SharePremium 2025-03-31 16357563 core:SharePremium 2026-04-30 16357563 core:RevaluationReserve 2025-03-31 16357563 core:RevaluationReserve 2026-04-30 16357563 core:CapitalRedemptionReserve 2025-03-31 16357563 core:CapitalRedemptionReserve 2026-04-30 16357563 core:CapitalContributionReserve 2025-03-31 16357563 core:CapitalContributionReserve 2026-04-30 16357563 core:OtherReservesSubtotal 2025-03-31 16357563 core:OtherReservesSubtotal 2026-04-30 16357563 core:RetainedEarningsAccumulatedLosses 2026-04-30 16357563 core:RetainedEarningsAccumulatedLosses 2025-03-31 iso4217:GBP xbrli:pure
Company Registration No. 16357563 (England and Wales)

BIOFYNDER LIMITED
Financial Statements
for the Period from 01 April 2025 to 30 April 2026

## BIOFYNDER LIMITED

### Financial Statements for the period ending 30 April 2026

CONTENTS | PAGE
Company Information | 2
Statement of Financial Position | 3
Notes to the Accounts | 4

## BIOFYNDER LIMITED

### Financial Statements for the period ending 30 April 2026

#### Company Information

Company Details
Company Number | 16357563
Registered Office | LAB 4, FIRST FLOOR EPSILON HOUSE
| ENTERPRISE ROAD, CHILWORTH
| SOUTHAMPTON
| SO16 7NS
Directors
Directors who held office during the period were:
HE, Peijun, Dr
Jingyang SUN

## BIOFYNDER LIMITED

### Financial Statements for the period ending 30 April 2026

#### Statement of Financial Position

12345678910

| Notes | 2026 |  |
|  | £ |  | £
Fixed Assets |  |  |  |
Investments | 5 | 978 |  | -
Current Assets |  |  |  |
Debtors due |  | 1,805 |  | -
Cash at bank and in hand |  | 7,603 |  | -
|  | 9,408 |  | -
Creditors |  |  |  |
Amount falling due within one year |  | (40,494) |  | -
Net Current Assets |  | (31,086) |  | -
Total Assets less current liabilities |  | (30,108) |  | -
Net Assets |  | (30,108) |  | -
Capital and Reserves |  |  |  |
Called up Share Capital |  | 10 |  | -
Retained earnings at end of year |  | (30,118) |  | -
Shareholder funds |  | (30,108) |  | -

For the year ending 30/04/2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities.
Approved by the Board on 13 August 2026
Peijun He, Director
Company Registration No. 16357563

## BIOFYNDER LIMITED

### Financial Statements for the period ending 30 April 2026

#### Notes to the Accounts

1. Statutory Information
BIOFYNDER LIMITED is a private company, limited by shares, registered in England and Wales, registration number 16357563.
2. Accounting Policies
Basis of preparing the Financial Statements
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities.The financial statements have been prepared under the historical cost convention, in sterling, which is the functional currency of the company. The company is entitled to exemption from preparing group accounts as the group qualifies as a small group.
Presentation Currency
The accounts are presented in £ sterling.
Turnover
Turnover represents amounts receivable for goods and services supplied in the ordinary course of business, net of discounts and sales taxes. Revenue is recognised when control of the goods or services passes to the customer.

## BIOFYNDER LIMITED

### Financial Statements for the period ending 30 April 2026

#### Notes to the Accounts

Current Tax
Current tax is recognised based on taxable profit for the period using tax rates enacted or substantively enacted at the reporting date. No Corporation Tax is payable for the period because the company incurred taxable trading losses.

## BIOFYNDER LIMITED

### Financial Statements for the period ending 30 April 2026

#### Notes to the Accounts

Stock
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined on a first-in, first-out basis. The company held no stock at the reporting date.
Deferred Tax
Deferred tax is recognised in respect of timing differences at rates expected to apply when they reverse. No deferred tax asset has been recognised in respect of tax losses because recovery is not considered sufficiently certain.

## BIOFYNDER LIMITED

### Financial Statements for the period ending 30 April 2026

#### Notes to the Accounts

3. Employees
Average number of employees, including directors, during the year was as follows:
2026 | 2
4. Principal Activity
The principal activity of the company during the period was the international trading and distribution of medical diagnostic products and related regulatory and commercial services.

## BIOFYNDER LIMITED

### Financial Statements for the period ending 30 April 2026

#### Notes to the Accounts

5. Investments |  |  |  |  |
| Investments in Subsidiaries |  | Other Investments - Listed |  | Other Investments -Unlisted |  | Total
| £ |  | £ |  | £ |  | £
Valuation at 01/04/2025 | - |  | - |  | - |  | -
Additions | 978 |  | - |  | - |  | 978
Disposals | - |  | - |  | - |  | -
Adjustments | - |  | - |  | - |  | -
Valuation at 30/04/2026 | 978 |  | - |  | - |  | 978